The realities of the changed market mean companies will have to rethink their commercialization tactics today to mitigate risk, keep momentum and thrive in the new future. As traditional access becomes increasingly difficult, adapting to a new digital environment is only a small part of the solution. Long-term success will come by pivoting commercialization strategies and adapting to new virtual interactions between field teams, health care providers (HCP) and patients. Syneos Health has identified four critical pivot points that biopharmaceutical companies should consider when planning for the short-term, mid-term and eventual restart reality.
Please watch this webinar where our featured experts will detail those four critical commercialization pivot points to help better plan for the new market reality.